Data / Drug companies / Pure Source, LLC
Pure Source, LLC: 26 products in the FDA NDC directory, labeler code 65121
Pure Source, LLC (labeler code 65121) lists 26 products in the FDA National Drug Code Directory. By type: 26 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on September 19, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65121
- Products in commercial distribution
- 26
- Packages
- 30
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 1, 2021
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 26 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 26 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 15 | 57.7% |
| Liquid | 5 | 19.2% |
| Lotion | 2 | 7.7% |
| Gel | 2 | 7.7% |
| Oil | 1 | 3.8% |
| Solution | 1 | 3.8% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Salicylic acid | 65121-538 | Cream | Drugs for further processing | September 19, 2024 |
| Benzoyl peroxide | 65121-537 | Cream | Drugs for further processing | September 19, 2024 |
| Homosalate, octisalate, octocrylene, avobenzone | 65121-553 | Lotion | Drugs for further processing | September 6, 2024 |
| Octisalate, octocrylene, avobenzone | 65121-552 | Oil | Drugs for further processing | September 6, 2024 |
| Menthol | 65121-551 | Cream | Drugs for further processing | September 6, 2024 |
| Titanium dioxide, zinc oxide | 65121-528 | Lotion | Drugs for further processing | August 19, 2024 |
| Benzocaine | 65121-554 | Liquid | Drugs for further processing | August 5, 2024 |
| Salicylic acid | 65121-520 | Liquid | Drugs for further processing | August 5, 2024 |
| Menthol | 65121-474 | Cream | Drugs for further processing | April 22, 2024 |
| Homosalate, octinoxate, avobenzone, octocrylene | 65121-473 | Cream | Drugs for further processing | April 22, 2024 |
| Benzocaine | 65121-469 | Gel | Drugs for further processing | March 11, 2024 |
| Homosalate, octinoxate, avobenzone, octocrylene | 65121-459 | Liquid | Drugs for further processing | February 26, 2024 |
| Salicylic acid | 65121-458 | Cream | Drugs for further processing | February 26, 2024 |
| Sulfur | 65121-457 | Cream | Drugs for further processing | February 26, 2024 |
| Salicylic acid | 65121-456 | Gel | Drugs for further processing | February 26, 2024 |
| Benzoyl peroxide | 65121-455 | Cream | Drugs for further processing | February 26, 2024 |
| Menthol | 65121-454 | Cream | Drugs for further processing | February 26, 2024 |
| Octinoxate, oxybenzone, titanium dioxide | 65121-453 | Cream | Drugs for further processing | February 26, 2024 |
| Homosalate, octinoxate, octisalate, zinc oxide | 65121-452 | Liquid | Drugs for further processing | February 26, 2024 |
| Lidocaine hydrochloride | 65121-451 | Cream | Drugs for further processing | February 26, 2024 |
| Homosalate, octinoxate, octocrylene, octisalate, avobenzone | 65121-437 | Liquid | Drugs for further processing | December 18, 2023 |
| Homosalate, ethylhexyl methoxycinnamate,butyl methoxydibenzoylmethane, octocrylene | 65121-652 | Cream | Drugs for further processing | October 26, 2023 |
| Butyl methoxydibenzoylmethane, ethylhexyl methoxycinnamate, homosalate, octocrylene | 65121-651 | Cream | Drugs for further processing | October 26, 2023 |
| Avobenzone, homosalate, octinoxate, octisalate, oxybenzone | 65121-493 | Cream | Drugs for further processing | June 19, 2023 |
| Undecylenic acid | 65121-207 | Solution | Drugs for further processing | September 1, 2021 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.